(in millions $) | 30 Oct 2024 | 1 May 2024 | 31 Dec 2023 | 30 Oct 2023 |
---|---|---|---|---|
Current assets | ||||
Cash | $174.31 | $176.8 | ||
Short term investments | ||||
Net receivables | $122.15 | $96.29 | ||
Inventory | ||||
Total current assets | $2131.97 | $2304.66 | ||
Long term investments | ||||
Property, plant & equipment | $97.4 | $99.84 | ||
Goodwill & intangible assets | $895.84 | $913.86 | ||
Total noncurrent assets | ||||
Total investments | $869.05 | $898.72 | ||
Total assets | $3468.18 | $3608.36 | ||
Current liabilities | ||||
Accounts payable | $305.01 | $296.06 | ||
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $1652.57 | $1753.99 | ||
Long term debt | $123.7 | $123.59 | ||
Total noncurrent liabilities | ||||
Total debt | $242.15 | $242.7 | ||
Total liabilities | $1802.33 | $1910.68 | ||
Shareholders' equity | ||||
Retained earnings | $131.34 | $165.24 | ||
Other shareholder equity | $0.19 | $0.34 | ||
Total shareholder equity | $761.84 | $794.66 |
(in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
---|---|---|---|---|
Current assets | ||||
Cash | $129.52 | $117.45 | $183.86 | $89.94 |
Short term investments | ||||
Net receivables | $98.77 | $53.51 | $39.57 | $34.81 |
Inventory | ||||
Total current assets | $2225.16 | $2984.99 | $1115.98 | |
Long term investments | ||||
Property, plant & equipment | $101.13 | $61.06 | $73.83 | $10.23 |
Goodwill & intangible assets | $935.19 | $978.67 | $12.28 | $15.62 |
Total noncurrent assets | ||||
Total investments | $916.43 | $1441.63 | $74.38 | $53.39 |
Total assets | $3497.4 | $4188.13 | $1320.77 | $680.83 |
Current liabilities | ||||
Accounts payable | $294.82 | $279.9 | $161.25 | $39.8 |
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $1745.17 | $1996.91 | $647.18 | |
Long term debt | $98.35 | $62.88 | ||
Total noncurrent liabilities | ||||
Total debt | $219.57 | $133.84 | $143.14 | |
Total liabilities | $1844.09 | $2363.8 | $661.08 | $443.86 |
Shareholders' equity | ||||
Retained earnings | $160.43 | $229.62 | $60.41 | $60.41 |
Other shareholder equity | $0.46 | $0.66 | $0.15 | $0.18 |
Total shareholder equity | $771.57 | $817.63 | $249.41 | $216.23 |
(in millions $) | 30 Oct 2024 | 1 May 2024 | 31 Dec 2023 | 30 Sep 2023 |
---|---|---|---|---|
Revenue | ||||
Total revenue | -$14.61 | $191.42 | ||
Cost of revenue | -$28.85 | $98.6 | ||
Gross Profit | $14.24 | $92.83 | ||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $48 | $31.73 | ||
Total operating expenses | $48 | $31.73 | ||
Operating income | -$33.77 | $61.1 | ||
Income from continuing operations | ||||
EBIT | -$18.39 | $36.06 | ||
Income tax expense | -$0.72 | $7.73 | ||
Interest expense | $2.56 | $2.11 | ||
Net income | ||||
Net income | -$20.23 | $26.23 | ||
Income (for common shares) | -$20.23 | $26.23 |
(in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
---|---|---|---|---|
Revenue | ||||
Total revenue | -$67.57 | $1365.53 | $787.72 | $446.61 |
Cost of revenue | -$214.24 | $802.7 | $411.06 | $242.3 |
Gross Profit | $146.66 | $562.83 | $376.65 | $204.31 |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $147.16 | $110.47 | $48.48 | $53.34 |
Total operating expenses | $147.16 | $110.47 | $48.48 | $53.34 |
Operating income | -$0.5 | $452.36 | $328.17 | $150.97 |
Income from continuing operations | ||||
EBIT | -$10.39 | $223.3 | $93.25 | $146.08 |
Income tax expense | $3.82 | $28.3 | $23.26 | $3.96 |
Interest expense | $4.19 | $1.11 | $7.36 | $10.21 |
Net income | ||||
Net income | -$18.4 | $193.88 | $62.63 | $131.92 |
Income (for common shares) | -$18.4 | $193.88 | $62.63 | $131.92 |
(in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
---|---|---|---|---|
Net income | -$20.23 | $26.23 | $21.27 | $28.8 |
Operating activities | ||||
Depreciation | $12.16 | $11.99 | $11.99 | $12.13 |
Business acquisitions & disposals | -$4.11 | -$0.25 | -$2.32 | -$0.95 |
Stock-based compensation | $14.21 | $5.92 | $8.47 | $9.34 |
Total cash flows from operations | $25.18 | $71.13 | $57.59 | -$0.52 |
Investing activities | ||||
Capital expenditures | -$4.09 | -$6.85 | -$7.76 | -$2.48 |
Investments | -$2.67 | -$5.82 | -$4.41 | -$3.97 |
Total cash flows from investing | -$10.86 | -$12.92 | -$14.49 | -$7.39 |
Financing activities | ||||
Dividends paid | -$13.45 | -$13.26 | -$28.28 | -$12.61 |
Sale and purchase of stock | ||||
Net borrowings | $25 | $15 | ||
Total cash flows from financing | -$13.8 | -$9.46 | -$43.97 | -$3.37 |
Effect of exchange rate | -$3.01 | $0.12 | -$0.72 | -$0.23 |
Change in cash and equivalents | -$2.49 | $48.87 | -$1.59 | -$11.51 |
(in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
---|---|---|---|---|
Net income | -$18.4 | $193.88 | $62.63 | $131.92 |
Operating activities | ||||
Depreciation | $47.44 | $26.98 | $5.5 | $7.08 |
Business acquisitions & disposals | -$8.82 | -$193.11 | ||
Stock-based compensation | $24.94 | $14 | $7.9 | $1.92 |
Total cash flows from operations | $151.18 | $214.28 | $149.3 | $65.93 |
Investing activities | ||||
Capital expenditures | -$5.63 | -$2.1 | -$1.26 | -$0.84 |
Investments | -$16.36 | -$15.06 | -$9.91 | $36.65 |
Total cash flows from investing | -$30.81 | -$210.24 | -$11.17 | $35.81 |
Financing activities | ||||
Dividends paid | -$49.97 | -$23.87 | -$2.05 | -$43.94 |
Sale and purchase of stock | $337.8 | |||
Net borrowings | $35 | $65 | -$147 | -$1.5 |
Total cash flows from financing | -$108.02 | -$70.44 | -$45.31 | -$52.17 |
Effect of exchange rate | -$0.29 | -$0.01 | $1.1 | -$0.25 |
Change in cash and equivalents | $12.07 | -$66.41 | $93.92 | $49.32 |
Best Income Stocks to Buy for April 15th
Zacks via Yahoo Finance
15 Apr 2024
|
Liberty All-Star ® Growth Fund, Inc. March 2024 Monthly Update By Investing.com
Investing.com
13 Apr 2024
|
StepStone Group (STEP) Surges 5.8%: Is This an Indication of Further Gains?
Zacks via Yahoo Finance
12 Apr 2024
|
Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher...
Benzinga
12 Apr 2024
|
StepStone’s stock rises after J.P. Morgan upgrades asset manger to overweight
Market Watch
12 Apr 2024
|
Auradine Raises $80 Million in Series B Round Before Bitcoin Halving
Cryptonews
11 Apr 2024
|
Best Income Stocks to Buy for April 10th
Zacks via Yahoo Finance
10 Apr 2024
|
Here's Why You Should Add Globe Life (GL) to Your Portfolio
Zacks
10 Apr 2024
|
StepStone Group (STEP) Upgraded to Strong Buy: Here's Why
Zacks via Yahoo Finance
4 Apr 2024
|
Best Income Stocks to Buy for April 4th
Zacks via Yahoo Finance
4 Apr 2024
|
Market cap | N/A |
---|---|
Enterprise value | N/A |
Shares outstanding | N/A |
Revenue | N/A |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
P/E ratio | N/A |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | N/A |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | N/A |
---|---|
ROA | N/A |
ROE | N/A |
Debt/Equity | 2.39 |
---|---|
Net debt/EBITDA | N/A |
Current ratio | N/A |
Quick ratio | N/A |